LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article: Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy.

Giacchetti, Sylvie / Faucheux, Lilith / Gardair, Charlotte / Cuvier, Caroline / de Roquancourt, Anne / Campedel, Luca / Groheux, David / de Bazelaire, Cedric / Lehmann-Che, Jacqueline / Miquel, Catherine / Cahen Doidy, Laurence / Amellou, Malika / Madelaine, Isabelle / Reyal, Fabien / Someil, Laetitia / Hocini, Hamid / Hennequin, Christophe / Teixeira, Luis / Espié, Marc /
Chevret, Sylvie / Soumelis, Vassili / Hamy, Anne-Sophie

Cancers

2022  Volume 14, Issue 5

Abstract: Background: Patients with triple-negative breast cancers (TNBC) have a poor prognosis unless a pathological complete response (pCR) is achieved after neoadjuvant chemotherapy (NAC). Few studies have analyzed changes in TIL levels following dose-dense ... ...

Abstract Background: Patients with triple-negative breast cancers (TNBC) have a poor prognosis unless a pathological complete response (pCR) is achieved after neoadjuvant chemotherapy (NAC). Few studies have analyzed changes in TIL levels following dose-dense dose-intense (dd-di) NAC. Patients and methods: From 2009 to 2018, 117 patients with TNBC received dd-di NAC at our institution. We aimed to identify factors associated with pre- and post-NAC TIL levels, and oncological outcomes relapse-free survival (RFS), and overall survival (OS). Results: Median pre-NAC and post-NAC TIL levels were 15% and 3%, respectively. Change in TIL levels with treatment was significantly correlated with metabolic response (SUV) and pCR. High post-NAC TIL levels were associated with a weak metabolic response after two cycles of NAC, with the presence of residual disease and nodal involvement at NAC completion. In multivariate analyses, high post-NAC TIL levels independently predicted poor RFS and poor OS (HR = 1.4 per 10% increment, 95%CI (1.1; 1.9) p = 0.014 and HR = 1.8 per 10% increment 95%CI (1.3−2.3), p < 0.0001, respectively). Conclusion: Our results suggest that TNBC patients with TIL enrichment after NAC are at higher risk of relapse. These patients are potential candidates for adjuvant treatment, such as immunotherapy, in clinical trials.
Language English
Publishing date 2022-03-04
Publishing country Switzerland
Document type Journal Article
ZDB-ID 2527080-1
ISSN 2072-6694
ISSN 2072-6694
DOI 10.3390/cancers14051331
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top